Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) was up 6.5% during trading on Thursday . The stock traded as high as $34.00 and last traded at $33.59. Approximately 51,187 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 50,104 shares. The stock had previously closed at $31.55. […]
Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 1.5% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s stock price shot up 0.9% on Tuesday . The company traded as high as $32.26 and last traded at $32.00. 46,582 shares changed hands during trading, a decline of 7% from the average session volume of 50,104 shares. The stock had previously closed at $31.70. Neoleukin Therapeutics […]
Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the appointment of Julie.
DSMB clears third pediatric patient for dosing in ongoing NGN-401 Phase 1/2 clinical trial for Rett syndrome; On track to dose third pediatric patient in early 1Q:24
CTA clearance obtained from UK.